Linked Life Data

21301335

Source:http://linkedlifedata.com/resource/pubmed/id/21301335

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-2-24
pubmed:abstractText
The aim is to compare the available evidence on the efficacy and safety of deoxycholate and lipid amphotericin B formulations (AMBF) in the treatment of invasive fungal disease (IFD) in neonates. The review also aims to summarize current practices and recommendations.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1535-3877
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
163-71
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy - is there a 'right' choice?
pubmed:affiliation
Paediatric Infectious Diseases Unit, St George's Hospital, London, UK.
pubmed:publicationType
Journal Article, Review